1. Home
  2. SKLZ vs CLSD Comparison

SKLZ vs CLSD Comparison

Compare SKLZ & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKLZ
  • CLSD
  • Stock Information
  • Founded
  • SKLZ 2012
  • CLSD 2011
  • Country
  • SKLZ United States
  • CLSD United States
  • Employees
  • SKLZ N/A
  • CLSD N/A
  • Industry
  • SKLZ EDP Services
  • CLSD Biotechnology: Pharmaceutical Preparations
  • Sector
  • SKLZ Technology
  • CLSD Health Care
  • Exchange
  • SKLZ Nasdaq
  • CLSD Nasdaq
  • Market Cap
  • SKLZ 87.6M
  • CLSD 76.6M
  • IPO Year
  • SKLZ N/A
  • CLSD 2016
  • Fundamental
  • Price
  • SKLZ $4.78
  • CLSD $1.02
  • Analyst Decision
  • SKLZ Buy
  • CLSD Strong Buy
  • Analyst Count
  • SKLZ 2
  • CLSD 6
  • Target Price
  • SKLZ $10.75
  • CLSD $5.33
  • AVG Volume (30 Days)
  • SKLZ 104.5K
  • CLSD 230.0K
  • Earning Date
  • SKLZ 11-07-2024
  • CLSD 11-12-2024
  • Dividend Yield
  • SKLZ N/A
  • CLSD N/A
  • EPS Growth
  • SKLZ N/A
  • CLSD N/A
  • EPS
  • SKLZ N/A
  • CLSD N/A
  • Revenue
  • SKLZ $106,198,000.00
  • CLSD $7,703,000.00
  • Revenue This Year
  • SKLZ N/A
  • CLSD N/A
  • Revenue Next Year
  • SKLZ $6.13
  • CLSD $91.87
  • P/E Ratio
  • SKLZ N/A
  • CLSD N/A
  • Revenue Growth
  • SKLZ N/A
  • CLSD 248.39
  • 52 Week Low
  • SKLZ $4.72
  • CLSD $0.92
  • 52 Week High
  • SKLZ $7.48
  • CLSD $2.12
  • Technical
  • Relative Strength Index (RSI)
  • SKLZ 32.93
  • CLSD 42.14
  • Support Level
  • SKLZ $4.75
  • CLSD $0.99
  • Resistance Level
  • SKLZ $4.98
  • CLSD $1.05
  • Average True Range (ATR)
  • SKLZ 0.18
  • CLSD 0.05
  • MACD
  • SKLZ -0.07
  • CLSD 0.00
  • Stochastic Oscillator
  • SKLZ 9.43
  • CLSD 15.38

About SKLZ Skillz Inc.

Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

About CLSD Clearside Biomedical Inc.

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Share on Social Networks: